Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
133.96
+0.14 (0.10%)
At close: Jul 14, 2026, 4:00 PM EDT
133.85
-0.11 (-0.08%)
After-hours: Jul 14, 2026, 7:34 PM EDT
Apogee Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $133 | Buy | Maintains | $133 | -0.72% | Jun 29, 2026 |
| Mizuho Securities | Mizuho Securities | Hold Downgrades $110 → $135 | Hold | Downgrades | $110 → $135 | +0.78% | Jun 24, 2026 |
| TD Cowen | TD Cowen | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jun 23, 2026 |
| Guggenheim | Guggenheim | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jun 23, 2026 |
| Citi | Citi | Hold Downgrades $125 → $135 | Hold | Downgrades | $125 → $135 | +0.78% | Jun 23, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $97 → $135 | Hold | Maintains | $97 → $135 | +0.78% | Jun 23, 2026 |
| UBS | UBS | Hold Downgrades $100 → $135 | Hold | Downgrades | $100 → $135 | +0.86% | Jun 23, 2026 |
| Deutsche Bank | Deutsche Bank | Hold Downgrades $116 → $135 | Hold | Downgrades | $116 → $135 | +0.78% | Jun 22, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.